Cabot Corporation CBT
72.00 USD -3.72 (-4.91%)
At closeNov 3, 2026, 4:03 PM EST
72.00 0.00 0.00%
After hours · Nov 3, 4:03 PM ET
70.76 Day range 75.10
58.33 52-week range 94.53
- YTD
- +8.63%
- 1 year
- +9.26%
Analyst view
Consensus: buy
Buy
Price target (mean) 89.50 +24.3% upside
Now 72.00
- Target (low)
- 78.00
- Target (mean)
- 89.50
- Target (high)
- 100.00
Ratings (0m) 6 2 buy · 3 hold · 1 sell
- Strong buy0
- Buy2
- Hold3
- Sell0
- Strong sell1
Recommendation trend
- This month 6
- 1 month ago 6
- 2 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.54 | 1.53 – 1.55 | 1.70 | -9.5% | 856.00M | +0.8% | 5 |
| Next quarter | 1.64 | 1.64 – 1.64 | 1.61 | +1.9% | 894.00M | -1.1% | 1 |
| Current year | 6.90 | 0.00 – 7.31 | 7.25 | -4.9% | 3.69B | -0.8% | 0 |
| Next year | 7.54 | 7.35 – 7.75 | 6.90 | +9.4% | 3.96B | +4.2% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 5, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 7, 2026 | JP Morgan | Maintained | Underweight | Underweight |
| Aug 5, 2026 | UBS | Maintained | Neutral | Neutral |
| Jun 25, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Jun 8, 2026 | Truist Securities | Initiated | — | Buy |
| May 13, 2026 | JP Morgan | Maintained | Underweight | Underweight |
| May 8, 2026 | UBS | Maintained | Neutral | Neutral |
| May 6, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Feb 5, 2026 | UBS | Maintained | Neutral | Neutral |
| Feb 5, 2026 | Mizuho | Downgrade | Outperform | Neutral |
| Jan 12, 2026 | UBS | Maintained | Neutral | Neutral |
| Dec 18, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Nov 28, 2025 | JP Morgan | Maintained | Underweight | Underweight |
| Nov 17, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Nov 5, 2025 | UBS | Maintained | Neutral | Neutral |
| Oct 3, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Aug 5, 2025 | UBS | Maintained | Neutral | Neutral |
| Apr 7, 2025 | UBS | Maintained | Neutral | Neutral |
| Feb 21, 2025 | JP Morgan | Maintained | Underweight | Underweight |
| Jan 7, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Nov 11, 2024 | JP Morgan | Downgrade | Neutral | Underweight |
| Nov 5, 2024 | Mizuho | Maintained | Outperform | Outperform |
| Aug 7, 2024 | JP Morgan | Maintained | Neutral | Neutral |
| Aug 6, 2024 | UBS | Maintained | Neutral | Neutral |
| May 7, 2024 | UBS | Maintained | Neutral | Neutral |
| May 7, 2024 | Mizuho | Maintained | Buy | Buy |
| Apr 18, 2024 | Deutsche Bank | Downgrade | Buy | Hold |
| Mar 27, 2024 | Mizuho | Initiated | — | Buy |
| Jan 8, 2024 | UBS | Downgrade | Buy | Neutral |
| Dec 14, 2023 | UBS | Maintained | Buy | Buy |